NPM1 is also frequently overexpressed in solid tumors of different histological origin (such as gastric, colon, ovarian, and prostate carcinomas) [30–33], however to date NPM1 mutations seem to be exclusively found in AML patients, although the relevance of splice variant expression remains undetermined. Here, NPM1 is linked to prostate carcinoma.